UPDATE: Goldman Sachs Downgrades Vir Biotechnology (VIR) to Neutral
Tweet Send to a Friend
(Updated - September 22, 2021 5:27 AM EDT)
Goldman Sachs analyst Paul Choi downgraded Vir Biotechnology (NASDAQ: VIR) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs analyst Paul Choi downgraded Vir Biotechnology (NASDAQ: VIR) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
